Biote (BTMD) Stock Price, Quote, News & History

Comments

Biote Corp (BTMD) Stock Price, Quote, News & History

BTMDNASDAQ

Trade with Public

$2.22

0.125.71%

At close: Apr 17, 5:00 PM EST

$2.22

N/A

After Hours: Apr 17, 4:00 PM EST

OverviewNews Earnings Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$2.15

Close

$2.22

Volume / Avg.

242.99K / 241.29K

Day Range

$2.15 - $2.28

52 Wk Range

1.27 - 4.75

Market Cap

$68.18M

P/E Ratio

2.84

Dividend Yield

-

Exchange

NASDAQ

RSI

72

Short Interest

6.02%

Days to Cover

4.82

Recent Biote Corp News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

35.19M

Investing Cash Flow (TTM)

-6.86M

Financing Cash Flow (TTM)

-43.56M

Free Cash Flow (TTM)

28.33M

Capital Expenditure (TTM)

-6.86M

Net Change in Cash (TTM)

-15.23M

Analyst Trends and Forecast

1

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$157.42M

PE Ratio (TTM)

2.84

PE Ratio (FWD)

4.37

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.40

PB Ratio (TTM)

-

Earnings Yield % (TTM)

35.24%

Earnings Yield % (FWD)

22.86%

EV / EBITDA (TTM)

2.93

Price / EBITDA (TTM)

1.47

Price / Free Cash Flow (TTM)

2.72

Book Value / Share

-$1.83

Company Debt

Total Debt

$107.03M

LT Debt

$100.78M

LT Debt Issuance (TTM)

$5.00M

LT Debt Repayment (TTM)

-$6.25M

Total Cash

$24.12M

Debt to Equity

-

Issuance of Debt (TTM)

-$1.25M

Repayment of Debt (TTM)

-$6.25M

Key Statistics

Open

$2.15

Close

$2.22

Volume / Avg.

242.99K / 241.29K

Day Range

$2.15 - $2.28

52 Wk Range

1.27 - 4.75

Market Cap

$68.18M

P/E Ratio

2.84

Dividend Yield

-

Exchange

NASDAQ

RSI

72

Short Interest

6.02%

Days to Cover

4.82

About

Sector

Health Care

Industry

Pharmaceuticals

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Biote (BTMD) stock?

A

You can purchase shares of Biote (NASDAQ:BTMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Biote (BTMD) competitors?

A

Other companies in Biote’s space includes: Cingulate Inc (NASDAQ:CING), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), SCYNEXIS Inc (NASDAQ:SCYX), Aardvark Therapeutics Inc (NASDAQ:AARD) and Rani Therapeutics Holdings Inc (NASDAQ:RANI).

Q

What is the forecast, or price target, for Biote (BTMD) stock?

A

Biote has a consensus price target of $5.58.

Q

What is the current price for Biote (BTMD)?

A

The stock price for Biote (NASDAQ: BTMD) is $2.22 last updated April 17, 2026 at 4:00 PM EDT.

Q

Does Biote (BTMD) pay a dividend?

A

There are no upcoming dividends for Biote.

Q

When is Biote (NASDAQ:BTMD) reporting earnings?

A

Biote does not have any upcoming earnings scheduled.

Q

Is Biote (BTMD) going to split?

A

There is no upcoming split for Biote.

Q

What sector and industry does Biote (BTMD) operate in?

A

Biote is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Cumberland Pharmaceuticals Inc

Aardvark Therapeutics Inc

NASDAQ:AARD

$5.23

%

Rani Therapeutics Holdings Inc

NASDAQ:RANI

$0.98

2.47%

Incannex Healthcare Inc

Telomir Pharmaceuticals Inc

NASDAQ:TELO

$1.39

-4.23%

Key Statistics

Open

$2.15

Close

$2.22

Volume / Avg.

242.99K / 241.29K

Day Range

$2.15 - $2.28

52 Wk Range

1.27 - 4.75

Market Cap

$68.18M

P/E Ratio

2.84

Dividend Yield

-

Exchange

NASDAQ

RSI

72

Short Interest

6.02%

Days to Cover

4.82

Recent Biote Corp News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

35.19M

Investing Cash Flow (TTM)

-6.86M

Financing Cash Flow (TTM)

-43.56M

Free Cash Flow (TTM)

28.33M

Capital Expenditure (TTM)

-6.86M

Net Change in Cash (TTM)

-15.23M

Analyst Trends and Forecast

1

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$157.42M

PE Ratio (TTM)

2.84

PE Ratio (FWD)

4.37

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.40

PB Ratio (TTM)

-

Earnings Yield % (TTM)

35.24%

Earnings Yield % (FWD)

22.86%

EV / EBITDA (TTM)

2.93

Price / EBITDA (TTM)

1.47

Price / Free Cash Flow (TTM)

2.72

Book Value / Share

-$1.83

Company Debt

Total Debt

$107.03M

LT Debt

$100.78M

LT Debt Issuance (TTM)

$5.00M

LT Debt Repayment (TTM)

-$6.25M

Total Cash

$24.12M

Debt to Equity

-

Issuance of Debt (TTM)

-$1.25M

Repayment of Debt (TTM)

-$6.25M

Key Statistics

Open

$2.15

Close

$2.22

Volume / Avg.

242.99K / 241.29K

Day Range

$2.15 - $2.28

52 Wk Range

1.27 - 4.75

Market Cap

$68.18M

P/E Ratio

2.84

Dividend Yield

-

Exchange

NASDAQ

RSI

72

Short Interest

6.02%

Days to Cover

4.82

About

Sector

Health Care

Industry

Pharmaceuticals

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry